Jerry S. Lanchbury - 14 Jan 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Reporting relationship: Officer
Issuer ticker: MYGN
Reported as of: 14 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jan 2022, 16:02:50 UTC
Prior SEC filing: 12 Oct 2021
Source filing: View source filing
Reporting owner signature: By: Nathan A. Smith For: Jerry S. Lanchbury

Filing notes and source

Key filing fact

Jerry S. Lanchbury filed Form 4 for MYRIAD GENETICS INC (MYGN) on 18 Jan 2022.

Key facts

This page summarizes Jerry S. Lanchbury's Form 4 filing for MYRIAD GENETICS INC (MYGN).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Jan 2022, 16:02.

Change

Previous filing in this sequence was filed on 12 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 264,324
Date: 14 Jan 2022
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Jerry S. Lanchbury is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

SEC remarks

Mr. Lanchbury's title is Former Chief Scientific Officer This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as the Company's Chief Scientific Officer, effective as of January 14, 2022, and therefore is no longer subject to Section 16 reporting